Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality

A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer

(2017) Bryan Oronsky et al.   MEDICAL ONCOLOGY

SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells

(2017) David Hamisi Mvunta et al.   Translational Oncology

Overexpression of SIRT1 is Associated With Poor Outcomes in Patients With Ovarian Carcinoma

(2017) David H. Mvunta et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma

(2016) Arcangela G Manente et al.   Epigenomics

An overview of early investigational therapies for chemoresistant ovarian cancer

(2015) Claudia Marchetti et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

JMJD3 as an epigenetic regulator in development and disease

(2015) Jana S. Burchfield et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC)

(2015) Ting Shuang et al.   MEDICAL ONCOLOGY

Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer

(2014) Karen Kar-Loen Chan et al.   JOURNAL OF ENDOCRINOLOGY

Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity

(2014) Giulia Pinton et al.   Molecular Cancer

Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer

(2012) Carine Bossard et al.   PLoS One

Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment

(2011) Neeraj Lalwani et al.   RADIOGRAPHICS

Estrogen Receptor Subtypes in Ovarian Cancer

(2010) Karen K. L. Chan et al.   OBSTETRICS AND GYNECOLOGY

First-line treatment of advanced ovarian cancer: current research and perspectives

(2009) Claudia Marchetti et al.   Expert Review of Anticancer Therapy

Expression and prognostic significance of SIRT1 in ovarian epithelial tumours

(2009) Kyu Yun Jang et al.   PATHOLOGY

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls

(2008)   LANCET

Estrogen Regulates Snail and Slug in the Down-Regulation of E-Cadherin and Induces Metastatic Potential of Ovarian Cancer Cells through Estrogen Receptor α

(2008) Se-Hyung Park et al.   MOLECULAR ENDOCRINOLOGY

Estrogen Receptors α and β as Determinants of Gene Expression: Influence of Ligand, Dose, and Chromatin Binding

(2008) Edmund C. Chang et al.   MOLECULAR ENDOCRINOLOGY

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

(2008) Martin Köbel et al.   PLOS MEDICINE